(Q38822001)

English

Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.

scientific article published on 5 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

multimodal imaging

1 reference

based on heuristic

inferred from title

Aurélien Corroyer-Dulmont

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Elodie A Pérès

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Eric T MacKenzie

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Myriam Bernaudin

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Aurélie N Gérault

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ariel Savina

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Fanny Bouquet

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Didier Divoux

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jérôme Toutain

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Méziane Ibazizène

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Louisa Barré

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Edwige Petit

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Samuel Valable

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

5 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

682-694

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Neuro-oncology: Glioblastoma--community adjusts to new standard of care

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

The paradoxical effect of bevacizumab in the therapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenation

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor model

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

In vivo imaging of vessel diameter, size, and density: a comparative study between MRI and histology

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Modeling Tumor-Associated Edema in Gliomas during Anti-Angiogenic Therapy and Its Impact on Imageable Tumor

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Tumor-associated edema in brain cancer patients: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Exploiting tumour hypoxia in cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Ionizing radiation-induced gene expression changes in TP53 proficient and deficient glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3225-0

21 January 2018

Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/26537287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26537287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/26537287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-015-3225-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38822001&oldid=2202116613"